Skip to main content
OpenTrials

Clinical trial condition

Lupus Erythematosus, Systemic

Explore clinical trials studying Lupus Erythematosus, Systemic. Study availability and eligibility vary by location and protocol.

867 public trials 228 recruiting studies
Refine in advanced search Browse all conditions

Lupus Erythematosus, Systemic trial results

Recruiting

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

NCT07085104

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Dermatomyositis, +24 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
  • University of Colorado Denver Aurora, Colorado, United States
  • Mayo Clinic Jacksonville, Florida, United States
View all 17 locations
View Trial Details
Recruiting

A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

NCT06897930

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • Research Site San Francisco, California, United States
  • Research Site Stanford, California, United States
  • Research Site Tampa, Florida, United States
  • Research Site Atlanta, Georgia, United States
View all 20 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Autoimmune Rheumatic Diseases

NCT06647069

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +9 more
Locations
  • Investigational Site Number : 001-201 Melbourne, Victoria, Australia
  • Investigational Site Number : 001-401 Sarajevo, Bosnia and Herzegovina
  • Investigational Site Number : 001-301 Auckland, New Zealand
  • Investigational Site Number : 001-801 Pretoria, South Africa
View Trial Details
Recruiting

A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132

NCT06875960

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE), +4 more
Locations
  • Local Institution - 0001 Farmington, Connecticut, United States
  • New York University School Of Medicine New York, United States
  • Oklahoma Medical Research Foundation Oklahoma City, Oklahoma, United States
  • Local Institution - 0003 Jackson, Tennessee, United States
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

NCT06617325

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Sl0044 50058 Avondale, Arizona, United States
  • Sl0044 50550 Chandler, Arizona, United States
  • Sl0044 50713 Gilbert, Arizona, United States
  • Sl0044 50662 Glendale, Arizona, United States
View all 242 locations
View Trial Details
Recruiting

A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

NCT07175285

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Local Institution - 0054 La Jolla, California, United States
  • Local Institution - 0001 La Palma, California, United States
  • Local Institution - 0071 Los Angeles, California, United States
  • Rheumatology Center of San Diego San Diego, California, United States
View all 66 locations
View Trial Details
Recruiting

A Study of LY4298445 in Healthy Participants and Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

NCT07276958

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +10 more
Locations
  • Nucleus Network Brisbane, Australia
  • Nucleus Network Melbourne, Australia
  • Peking University First Hospital Beijing, China
  • Peking University Third Hospital Beijing, China
View Trial Details
Recruiting

Clinical Study of Cizutamig in Systemic Lupus Erythematosus

NCT07215663

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Chinese Academy of Medical Sciences and Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
  • Nanfang Hospital Southern Medical University Guangzhou, Guangdong, China
  • Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China
View all 17 locations
View Trial Details

Related conditions